TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot helps diabetics shed pounds in major trial
Disease control OngoingThis study tests a new medication, maridebart cafraglutide, to help adults with type 2 diabetes who are overweight or obese lose weight. About 1,100 participants will receive either the drug or a placebo for 72 weeks. The main goal is to see how much weight they lose and if it im…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Handheld scanners could spot silent killers before symptoms start
Diagnosis ENROLLING_BY_INVITATIONThis study tests if portable devices like handheld ultrasound and blood glucose monitors can find chronic diseases such as diabetes, heart disease, and kidney disease earlier than standard care. About 200 adults aged 18 to 75 will use these devices or receive usual care for 6 mon…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated May 26, 2026 12:08 UTC